Clinical Trials for Nektar Therapeutics

Explore 6 clinical trials worldwide

Showing 1-6 of 6 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Nektar Therapeutics

Clinical Trials (6)

NCT06340360
A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA)
PHASE2Active, not recruiting
94 participants
Started: Apr 2, 2024 · Completed: Aug 31, 2026
1 condition1 sponsor28 locations
NCT05676749
C-TIL051 in Non-Small Cell Lung Cancer
PHASE1Recruiting
20 participants
Started: Feb 29, 2024 · Completed: Aug 31, 2027
1 condition2 sponsors4 locations
NCT06136741
A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic Dermatitis
PHASE2Active, not recruiting
396 participants
Started: Nov 15, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor107 locations
NCT05632809
REStoring lymphoCytes Using NKTR-255* After chemoradiothErapy in Solid Tumors (RESCUE)
PHASE2Recruiting
39 participants
Started: Jan 10, 2023 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT05359211
NKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell Lymphoma
PHASE1Active, not recruiting
28 participants
Started: Dec 8, 2022 · Completed: Sep 4, 2026
9 conditions2 sponsors1 location
NCT05327530
A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley)
PHASE2Active, not recruiting
256 participants
Started: Aug 17, 2022 · Completed: Jun 25, 2026
1 condition2 sponsors97 locations